Critical illness neuromyopathy

Clinical Pulmonary Medicine

Volumn 12, Issue 2, 2005, Pages 90-96

  De Jonghe, Bernard ^a   Sharshar, Tarek ^b   Lefaucheur, Jean Pascal ^c   Outin, Hervé ^a  

^a CENTRE HOSPITALIER INTERCOMMUNAL   (France)

^b RAYMOND POINCARÉ HOSPITAL   (France)

^c HENRI MONDOR HOSPITAL   (France)

Author keywords

Corticosteroids; Insulin; Intensive care unit; Mechanical ventilation; Neuromuscular abnormalities; Organ dysfunction; Paralysis

Indexed keywords

CORTICOSTEROID; NEUROMUSCULAR BLOCKING AGENT; SEDATIVE AGENT; STEROID; SUXAMETHONIUM; VECURONIUM;

ARTIFICIAL VENTILATION; CARDIOPULMONARY INSUFFICIENCY; CLINICAL FEATURE; CRITICAL ILLNESS; ELECTROPHYSIOLOGY; FACE MUSCLE; HEART SURGERY; HUMAN; HYPERGLYCEMIA; HYPERKALEMIA; IMMOBILIZATION; INTENSIVE CARE UNIT; MEMBRANE DEPOLARIZATION; MULTIPLE ORGAN FAILURE; MUSCLE ACTION POTENTIAL; MUSCLE CONTRACTION; MUSCLE DENERVATION; MUSCLE FIBER MEMBRANE; MUSCLE INJURY; MUSCLE STRENGTH; MUSCLE WEAKNESS; NERVE STIMULATION; NEUROMUSCULAR DISEASE; NEUROPATHY; REVIEW; RISK FACTOR; VALIDATION PROCESS;

EID: 14944372175     PISSN: 10680640     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.cpm.0000156639.67261.19     Document Type: Review

References (57)

1. Bolton CF, Gilbert JJ, Hahn A, et al. Polyneuropathy in critically ill patients. J Neurol Neurosurg Psychiatr. 1984;47:1223-1231.
2. Couturier J, Robert D, Monier P. Polynevrites compliquant des séjours prolongés en réanimation. Lyon Med. 1984;252:247-249.
3. Bolton C, Laverty D, Brown J, et al. Critically ill polyneuropathy: electrophysiologic studies and differences from Guillain-Barré syndrome. J Neurol Neurosurg Psychiatr. 1986;49:563-573.
4. MacFarlane IA, Rosenthal FD. Severe myopathy after status asthmaticus. Lancet. 1977;ii:615.
5. Douglass J. Myopathy in severe asthma. Am Rev Respir Dis. 1992;146:517-519.
6. Helliwell T, Coakley J, Wagenmakers A, et al. Necrotizing myopathy in critically-ill patients. J Pathol. 1991;164:307-314.
7. Coakley J. Preliminary observations on the neuromuscular abnormalities in patients with organ failure and sepsis. Intensive Care Med. 1993;19:323-328.
8. Kupfer Y. Prolonged weakness after long-term infusion of vecuronium bromide. Ann Intern Med. 1992;117:484-486.
9. Bednarik J, Lukas Z, Vondracek P. Critical illness polyneuromyopathy: the electrophysiological components of a complex entity. Intensive Care Med. 2003;29:1505-1514.
10. Kleyweg RP, van der Meche FG, Meulstee J. Treatment of Guillain-Barré syndrome with high-dose gammaglobulin. Neurology. 1988;38:1639-1641.
11. Kleyweg RP, van der Meché FG, Schmitz PI. Interobserver agreement in the assessment of muscle strength and functional abilities in Guillain-Barré syndrome. Muscle Nerve. 1991;14:1103-1109.
12. Latronico N, Rasulo FA, Recupero D, et al. Acute quadriplegia with delayed onset and rapid recovery: case report. J Neurosurg. 1998;88:769-772.
13. De Jonghe B, Cook D, Sharshar T, et al. Acquired neuromuscular disorders in critically ill patients: a systematic review. Intensive Care Med. 1998;24:1242-1250.
14. Rich M, Teener J, Raps E, et al. Muscle is electrically inexcitable in acute quadriplegic myopathy. Neurology. 1996;46:731-735.
15. Rich MM, Bird SJ, Raps EC, et al. Direct muscle stimulation in acute quadriplegic myopathy. Muscle Nerve. 1997;20:665-673.
16. Rich MM, Pinter MJ, Kraner SD, et al. Loss of electrical excitability in an animal model of acute quadriplegic myopathy. Ann Neurol. 1998;43:171-179.
17. Rich MM, Pinter MJ. Crucial role of sodium channel fast inactivation in muscle fibre inexcitability in a rat model of critical illness myopathy. J Physiol. 2003;547:555-566.
18. Trojaborg W, Weimer LH, Hays AP. Electrophysiologic studies in critical illness associated weakness: myopathy or neuropathy: a reappraisal. Clin Neurophysiol. 2001;112:1586-1593.
19. Tennila A, Salmi T, Pettila V, et al. Early signs of critical illness polyneuropathy in ICU patients with systemic inflammatory response syndrome or sepsis. Intensive Care Med. 2000;26:1360-1363.
20. Tepper M, Rakic S, Haas JA, et al. Incidence and onset of critical illness polyneuropathy in patients with septic shock. Neth J Med. 2000;56:211-214.
21. De Jonghe B, Sharshar T, Lefaucheur JP, et al. Paresis acquired in the intensive care unit: a prospective multicenter study. JAMA. 2002;288:2859-2867.
22. Leijten FS, Harinck-de-Weerd JE, Poortvliet DC, et al. The role of polyneuropathy in motor convalescence after prolonged mechanical ventilation. JAMA. 1995;275:442-443.
23. Thiele RI, Jakob H, Hund E, et al. Critical illness polyneuropathy: a new iatrogenically induced syndrome after cardiac surgery? Eur J Cardiothorac Surg. 1997;12:826-835.
24. Thiele RI, Jakob H, Hund E, et al. Sepsis and catecholamine support are the major risk factors for critical illness polyneuropathy after open heart surgery. Thorac Cardiovasc Surg. 2000;48:145-150.
25. Garnacho-Montero J, Madrazo-Osuna J, Garcia-Garmendia JL, et al. Critical illness polyneuropathy: risk factors and clinical consequences: a cohort study in septic patients. Intensive Care Med. 2001;27:1288-1296.
26. De Jonghe B, Bastuji-Garin S, Sharshar T, et al. Does ICU-acquired paresis lengthen weaning from mechanical ventilation? Intensive Care Med. 2004;30:1117-1121.
27. Maher J, Rutledge F, Remtulla H, et al. Neuromuscular disorders associated with failure to wean from the ventilator. Intensive Care Med. 1995;21:737-743.
28. Witt NJ, Zochodne DW, Bolton CF, et al. Peripheral nerve function in sepsis and multiple organ failure. Chest. 1991;99:176-184.
29. van der Schaaf M, Beelen A, de Groot IJ. Critical illness polyneuropathy: a summary of the literature on rehabilitation outcome. Disabil Rehabil. 2000;22:808-810.
30. Herridge MS, Cheung AM, Tansey CM, et al. One-year outcomes in survivors of the acute respiratory distress syndrome. N Engl J Med. 2003;348:683-693.
31. Fletcher SN, Kennedy DD, Ghosh IR, et al. Persistent neuromuscular and neurophysiologic abnormalities in long-term survivors of prolonged critical illness. Crit Care Med. 2003;31:1012-1016.
32. De Jonghe B, Cook D, Outin H. Risk factors for polyneuromyopathy of critical illness. In: Yearbook of Intensive Care and Emergency Medicine. Berlin: Springer-Verlag; 1999:322-330.
33. Campellone JV, Lacomis D, Kramer DJ, et al. Acute myopathy after liver transplantation. Neurology. 1998;50:46-53.
34. de Letter MA, Schmitz PI, Visser LH, et al. Risk factors for the development of polyneuropathy and myopathy in critically ill patients. Crit Care Med. 2001;29:2281-2286.
35. Bolton C. Sepsis and the systemic inflammatory response syndrome: neuromuscular manifestations. Crit Care Med. 1996;24:1408-1416.
36. Verheul GA, de Jongh-Leuvenink J, Op de Coul AA, et al. Tumor necrosis factor and interleukin-6 in critical illness polyneuromyopathy. Clin Neurol Neurosurg. 1994;96:300-304.
37. De Letter MA, van Doorn PA, Savelkoul HF, et al. Critical illness polyneuropathy and myopathy (CIPNM): evidence for local immune activation by cytokine-expression in the muscle tissue. J Neuroimmunol. 2000;106:206-213.
38. Sassoon CS, Caiozzo VJ, Manka A, et al. Altered diaphragm contractile properties with controlled mechanical ventilation. J Appl Physiol. 2002;92:2585-2595.
39. Segredo V, Caldwell J, Matthay M, et al. Persistent paralysis in critically ill patients after long-term administration of vecuronium. N Engl J Med. 1992;327:524-528.
40. Leatherman J, Fluegel W, David W, et al. Muscle weakness in mechanically ventilated patients with severe asthma. Am J Respir Crit Care Med. 1996;153:1686-1690.
41. Behbehani NA, Al-Mane F, D'Yachkova Y, et al. Myopathy following mechanical ventilation for acute severe asthma: the role of muscle relaxants and corticosteroids. Chest. 1999;115:1627-1631.
42. Adnet F, Dhissi G, Borron SW, et al. Complication profiles of adult asthmatics requiring paralysis during mechanical ventilation. Intensive Care Med. 2001;27:1729-1736.
43. Konagaya M, Bernard PA, Max SR. Blockade of glucocorticoid receptor binding and inhibition of dexamethasone-induced muscle atrophy in the rat by RU38486, a potent glucocorticoid antagonist. Endocrinology. 1986;119:375-380.
44. Sun X, Mammen JM, Tian X. Sepsis induces the transcription of the glucocorticoid receptor in skeletal muscle cells. Clin Sci (Lond). 2003;105:383-391.
45. Du Bois DC, Almon RR. A possible role for glucocorticoids in denervation atrophy. Muscle Nerve. 1981;4:370-373.
46. van den Berghe G, Wouters P, Weekers F, et al. Intensive insulin therapy in the critically ill patients. N Engl J Med. 2001;345:1359-1367.
47. van den Berghe G, Wouters PJ, Bouillon R, et al. Outcome benefit of intensive insulin therapy in the critically ill: insulin dose versus glycemic control. Crit Care Med. 2003;31:359-366.
48. Griffiths RD, Palmer TE, Helliwell T, et al. Effect of passive stretching on the wasting of muscle in the critically ill. Nutrition. 1995;11:428-432.
49. Brook AD, Ahrens TS, Schaiff R, et al. Effect of a nursing-implemented sedation protocol on the duration of mechanical ventilation. Crit Care Med. 1999;27:2609-2615.
50. Kress J, Pohlman A, O'Connor M, et al. Daily interruption of sedative infusions in critically ill patients undergoing mechanical ventilation. N Engl J Med. 2000;342:1471-1477.
51. Annane D, Sebille V, Charpentier C, et al. Effect of treatment with low doses of hydrocortisone and fludrocortisone on mortality in patients with septic shock. JAMA. 2002;288:862-871.
52. Meduri GU, Headley AS, Golden E, et al. Effect of prolonged methyl-prednisolone therapy in unresolving acute respiratory distress syndrome: a randomized controlled trial. JAMA. 1998;280:159-165.
53. Horton WA, Fergusson NV. Hyperkalaemia and cardiac arrest after the use of suxamethonium in intensive care. Anaesthesia. 1988;43:890-891.
54. Hemming AE, Charlton S, Kelly P. Hyperkalaemia, cardiac arrest, suxamethonium and intensive care. Anaesthesia. 1990;45:990-991.
55. Dornan RI, Royston D. Suxamethonium-related hyperkalaemic cardiac arrest in intensive care. Anaesthesia. 1995;50:1006.
56. Markewitz BA, Elstad MR. Succinylcholine-induced hyperkalemia following prolonged pharmacologic neuromuscular blockade. Chest. 1997;111:248-250.
57. Hughes M, Grant IS, Biccard B, et al. Suxamethonium and critical illness polyneuropathy. Anaesth Intensive Care. 1999;27:636-638.